CRL vs XGN · rev $2.00B vs rev $37.2M
Charles River Laboratories (CRL) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported XGN revenue for 2026-06-30 was $37.2M. Net income was -$7.2M. XGN currently screens at market cap $154.1M.
CRL currently screens at market cap $7.78B. XGN currently screens at market cap $154.1M.
Not investment advice. Open the CRL and XGN stock pages for the full models.
Not investment advice.